ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 15 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,870,000 | +2.2% | 2,750,000 | 0.0% | 0.01% | +80.0% |
| Q1 2022 | $1,830,000 | +38.5% | 2,750,000 | +57.1% | 0.01% | +150.0% |
| Q4 2021 | $1,321,000 | +5.8% | 1,750,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,248,000 | +8.8% | 1,750,000 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,147,000 | -1.5% | 1,750,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,165,000 | +15.0% | 1,750,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,013,000 | -51.4% | 1,750,000 | -46.2% | 0.00% | -72.7% |
| Q3 2020 | $2,084,000 | -10.2% | 3,250,000 | 0.0% | 0.01% | -26.7% |
| Q2 2020 | $2,321,000 | +28.2% | 3,250,000 | 0.0% | 0.02% | -48.3% |
| Q1 2020 | $1,811,000 | -42.4% | 3,250,000 | -18.8% | 0.03% | +70.6% |
| Q4 2019 | $3,143,000 | -3.2% | 4,000,000 | 0.0% | 0.02% | -22.7% |
| Q3 2019 | $3,248,000 | -4.0% | 4,000,000 | 0.0% | 0.02% | -8.3% |
| Q2 2019 | $3,385,000 | – | 4,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cowen Prime Advisors LLC | 7,580,000 | $5,330,000 | 1.98% |
| Samjo Capital LLC | 2,600,000 | $1,828,000 | 1.34% |
| PenderFund Capital Management Ltd. | 5,560,000 | $5,031,000 | 1.32% |
| Indaba Capital Management, L.P. | 11,000,000 | $7,698,000 | 0.82% |
| Saltoro Capital, LP | 900,000 | $642,000 | 0.23% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 8,000,000 | $5,625,000 | 0.08% |
| WOLVERINE ASSET MANAGEMENT LLC | 4,000,000 | $2,814,000 | 0.02% |
| INGALLS & SNYDER LLC | 815,000 | $532,000 | 0.02% |
| BlueCrest Capital Management Ltd | 1,000,000 | $662,000 | 0.02% |
| Citadel Advisors | 65,655,000 | $46,617,000 | 0.01% |